Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.
Email me when S 1414 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1414. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The Expedited Access to Biosimilars Act would create a faster pathway for biosimilar drugs to reach the market, potentially lowering costs for patients. It targets pharmaceutical manufacturers, healthcare providers, and consumers who rely on biologic therapies, and it has been favorably reported by the Senate Health, Education, Labor, and Pensions Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1414
3 free questions a day, no accountHistory
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate
Sponsors
- Sen. Paul, Rand [R-KY] (R) · sponsor
- Sen. Lee, Mike [R-UT] (R)
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1414 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1414 freeOr ask your AI assistant about S 1414 directly:
Add to Claude, ChatGPT or Cursor